In this study, we identified yet another CSC marker; COL17A1, a novel TP53 target [42] and a frequently mutating gene in breast cancer (Table S3), is known to be involved in the regulation of both cell migration and invasion [42,43]. The gene discussed is TP53; the disease is breast cancer.